UBS Downgrades Dorian LPG to Neutral, Announces $19 Price Target
UBS analyst Brian Reynolds downgrades Dorian LPG (NYSE:LPG) from Buy to Neutral and announces $19 price target.
Cowen & Co. Downgrades C.H. Robinson Worldwide to Market Perform, Announces $91 Price Target
Cowen & Co. analyst Jason Seidl downgrades C.H. Robinson Worldwide (NASDAQ:CHRW) from Outperform to Market Perform and announces $91 price target.
B of A Securities Downgrades Applied Molecular to Underperform, Lowers Price Target to $0.5
B of A Securities analyst Jason Gerberry downgrades Applied Molecular (NASDAQ:AMTI) from Buy to Underperform and lowers the price target from $5 to $0.5.
Credit Suisse Downgrades Nomad Foods to Neutral, Lowers Price Target to $20
Credit Suisse analyst Robert Moskow downgrades Nomad Foods (NYSE:NOMD) from Outperform to Neutral and lowers the price target from $25 to $20.
Credit Suisse Downgrades Danaher to Neutral, Lowers Price Target to $300
Credit Suisse analyst Dan Leonard downgrades Danaher (NYSE:DHR) from Outperform to Neutral and lowers the price target from $315 to $300.
Wolfe Research Downgrades Cano Health to Peer Perform
Wolfe Research analyst Justin Lake downgrades Cano Health (NYSE:CANO) from Outperform to Peer Perform.
Piper Sandler Downgrades Wolverine World Wide to Neutral, Lowers Price Target to $13
Piper Sandler analyst Abbie Zvejnieks downgrades Wolverine World Wide (NYSE:WWW) from Overweight to Neutral and lowers the price target from $23 to $13.
Headwinds Including Peak NII, Higher Beta Sensitivity, Slower NNA Forces Analyst To Double Downgrade Morgan Stanley
Wolfe Research analyst Steven Chubak downgraded Morgan Stanley (NYSE: MS) from Outperform to Un
Goldman Sachs’ Four Zones Within Capital Market Coverage, Gives Stock Picks
Goldman Sachs Group Inc (NYSE: GS) has outlined four themes for 2023 amid recessionary risks and rising interest rates.
Overstock.com’s Market Share Erosion Triggers Downgrade By This Analyst
Needham analyst Anna Andreeva downgraded Overstock.com (NASDAQ:OSTK) from Buy to Hold and removed the $30 price target. The analyst said through 3Q22, home…